Skip to content

For in vitro research use only. Not for human or animal consumption.

VaultLabs logo
Research use only24h dispatchLot-tracked COA

Short-peptide research

Selank

Selank is the synthetic heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro, a tuftsin-related sequence that ends in Pro-Gly-Pro. VaultLabs supplies it as a 10 mg lyophilized vial at the same AED price as Semax 10 mg. It is not Semax (Met-Glu-His-Phe-Pro-Gly-Pro, CAS 80714-61-0) and it is not the Selank + Semax blend. CAS 129954-34-3. Formula C33H57N11O9. Molecular weight 751.9 g/mol. It is not an approved medicine.

Research use only. For in vitro research use only. Not for human or animal consumption. Not for human consumption, medical use, or personal application.

Reviewed by VaultLabs Research Editorial Desk · Last updated 2026-10-20

Key facts

  • Sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro.
  • CAS 129954-34-3. Formula C33H57N11O9. Molecular weight 751.9 g/mol.
  • Not Semax, and not the Selank + Semax blend.
  • Catalogue fill is 10 mg, priced the same as Semax 10 mg.
  • Indexed papers are literature context, not a product claim and not a lot certificate.
  • Supplied for laboratory research. Not for human use.
Chemical name
Selank
Sequence
Thr-Lys-Pro-Arg-Pro-Gly-Pro
CAS number
129954-34-3
Molecular formula
C33H57N11O9
Molecular weight
751.9 g/mol
Catalog strength
10 mg vial

What Selank is

Selank and Semax are both seven-residue peptides with a C-terminal Pro-Gly-Pro, which is why purchase orders keep pairing them. The first four residues are not the same. Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, CAS 129954-34-3, 751.9 g/mol. Semax is Met-Glu-His-Phe-Pro-Gly-Pro, CAS 80714-61-0, 813.87 g/mol. A shared three-residue tail is not an identity match. The lot record has to name the sequence that is in the vial.

Selank is the synthetic heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro, a tuftsin-related sequence that ends in Pro-Gly-Pro. VaultLabs supplies it as a 10 mg lyophilized vial at the same AED price as Semax 10 mg. It is not Semax (Met-Glu-His-Phe-Pro-Gly-Pro, CAS 80714-61-0) and it is not the Selank + Semax blend. CAS 129954-34-3. Formula C33H57N11O9. Molecular weight 751.9 g/mol. It is not an approved medicine.

How VaultLabs catalogues it

One fill: Selank 10mg, at the same AED price as Semax 10mg. Selank + Semax 10mg is a dual-peptide lot with no single CAS. Do not substitute one of these three for another. The side-by-side identity note is Semax versus Selank.

Write Selank, 10 mg, and the lot. A certificate for Semax does not release this vial. A certificate for the blend does not release this vial. A photograph of a label is not a laboratory report.

Lots and receiving

Each sealed unit carries its own lot number. The certificate for that lot is the purity record, and it is published on the batch page when the laboratory report for that unit is on file. Until that report is published, the purity figure is not copied from a catalogue average, from a label photograph, or from a paper. A certificate for Semax does not qualify this vial. A certificate for the Selank + Semax blend does not qualify this single-sequence vial. Match the printed name, the nominal mass and the lot number on the vial to the published record. If those three do not agree, or if no record is published yet, hold the unit and ask for the document that belongs to that unit before it leaves quarantine. Enter the printed lot at batch verification.

Storage and research-use boundary

Keep the sealed lyophilized vial at 2 to 8 degrees Celsius, protected from light and from moisture, until it is opened under the laboratory's own procedure. Allow the closed vial to reach room temperature before the seal is broken, so water from humid coastal air does not condense on the dry cake. Bacteriostatic water and sterile water are separate catalogue lines. They are not packed inside the peptide box, because the receiving laboratory chooses the medium in its own procedure. VaultLabs does not publish a preparation method on this page. After the seal is opened, solution age, container and freeze cycles are controlled by the laboratory, not by the catalogue page.

The material is supplied for in vitro laboratory research only. It is not for human or animal consumption. It is not an approved medicine, not a finished cosmetic, and not a personal-use item. Papers cited on the compound monograph describe other people's experiments. Those papers are not a description of what this vial will do, and they are not instructions for any person or animal. A buyer who needs a registered medicine should use a licensed pharmacy channel. This page exists so a procurement officer in the UAE can identify the catalogue line, the fill, the price band and the paperwork before raising an order.

Research interest areas

Sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro.

CAS 129954-34-3. Formula C33H57N11O9. Molecular weight 751.9 g/mol.

Not Semax, and not the Selank + Semax blend.

Catalogue fill is 10 mg, priced the same as Semax 10 mg.

Storage information

2–8 °C (lyophilized, sealed)

2–8 °C sealed lyophilized storage, protected from light and humidity.

Stability notes

Keep the sealed lyophilized vial at 2 to 8 degrees Celsius, protected from light and from moisture, until it is opened under the laboratory's own procedure. Allow the closed vial to reach room temperature before the seal is broken, so water from humid coastal air does not condense on the dry cake. Bacteriostatic water and sterile water are separate catalogue lines. They are not packed inside the peptide box, because the receiving laboratory chooses the medium in its own procedure. VaultLabs does not publish a preparation method on this page. After the seal is opened, solution age, container and freeze cycles are controlled by the laboratory, not by the catalogue page.

Selected literature

Named papers behind the statements on this page. Each entry resolves on PubMed and through its DOI, so you can read the source rather than take our summary of it. Inclusion describes the research record and is not a claim about this material’s suitability for any use.

  1. Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats.

    Konstantinopolsky MA, et al. · Bulletin of Experimental Biology and Medicine · 2022

    Rat literature on the tuftsin analogue. Cited so the name can be traced. Not a VaultLabs result and not a use instruction.

    PubMed 36322304doi:10.1007/s10517-022-05624-x

  2. [Changes in expression of the genes for chemokines, cytokines, and their receptors in response to selank and its fragments].

    Kolomin TA, et al. · Genetika · 2011

    Gene-expression paper on Selank and shorter fragments. Literature context, not a lot certificate and not a use instruction.

    PubMed 21786679

Databases and verification

Registry and database entries for independent identity checks. These are standing searches rather than fixed records, so they stay current as new work is indexed.

FAQ

No. Selank reference materials from VaultLabs are for in vitro laboratory research only under qualified institutional workflows.

Use batch verification on vaultlabs.shop with the lot printed on the vial. If that lot is not published yet, the lab report is available on request.

Sealed lyophilized material at 2–8 °C, protected from light and moisture, until it is opened under the laboratory's own procedure.

No. Selank is Thr-Lys-Pro-Arg-Pro-Gly-Pro, CAS 129954-34-3. Semax is Met-Glu-His-Phe-Pro-Gly-Pro, CAS 80714-61-0. The Selank + Semax blend is a third lot and has no single CAS.

No. A paper describes someone else's experiment. The lot record is the document that matches the vial in hand.